â‚©
9340.00
Jan 3
Business Description
Inbiogen
ISIN : KR7101140002
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.92 | |||||
Equity-to-Asset | 0.98 | |||||
Debt-to-EBITDA | 0.49 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 16.2 | |||||
Beneish M-Score | -1.85 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -47.1 | |||||
3-Year EPS without NRI Growth Rate | 61.5 | |||||
3-Year FCF Growth Rate | 66.6 | |||||
3-Year Book Growth Rate | -21.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.18 | |||||
Quick Ratio | 3.95 | |||||
Cash Ratio | 2.19 | |||||
Days Inventory | 62.08 | |||||
Days Sales Outstanding | 208.2 | |||||
Days Payable | 20.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -58.1 | |||||
Shareholder Yield % | 1.1 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 10.05 | |||||
Operating Margin % | -85.06 | |||||
Net Margin % | 11.81 | |||||
FCF Margin % | -16.96 | |||||
ROE % | 0.5 | |||||
ROA % | 0.49 | |||||
ROIC % | -3.69 | |||||
ROC (Joel Greenblatt) % | -2.18 | |||||
ROCE % | -0.08 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 123.43 | |||||
PE Ratio without NRI | 80.07 | |||||
Price-to-Owner-Earnings | 36.98 | |||||
PS Ratio | 14.49 | |||||
PB Ratio | 0.62 | |||||
Price-to-Tangible-Book | 0.62 | |||||
EV-to-EBIT | -484.14 | |||||
EV-to-EBITDA | 56.99 | |||||
EV-to-Revenue | 9.09 | |||||
EV-to-FCF | -53.56 | |||||
Price-to-Projected-FCF | 1.47 | |||||
Price-to-Median-PS-Value | 1.99 | |||||
Price-to-Graham-Number | 1.49 | |||||
Price-to-Net-Current-Asset-Value | 15.35 | |||||
Price-to-Net-Cash | 46.05 | |||||
Earnings Yield (Greenblatt) % | -0.21 | |||||
FCF Yield % | -1.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Inbiogen Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 6,435.701 | ||
EPS (TTM) (â‚©) | 75.668 | ||
Beta | 1.31 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (â‚©) | 0 | ||
20-Day SMA (â‚©) | 9340 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (â‚©) | 9340 - 9340 | ||
Shares Outstanding (Mil) | 9.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Inbiogen Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Inbiogen Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Inbiogen Frequently Asked Questions
What is Inbiogen(XKRX:101140)'s stock price today?
When is next earnings date of Inbiogen(XKRX:101140)?
Does Inbiogen(XKRX:101140) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |